Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of disability and low quality of life. One in every three people suffering from MDD ...

SNRI use in late pregnancy was associated with an increased risk for hypertensive disorders compared with SSRIs (adjusted hazard ratio [aHR], 1.80; 95% CI, 1.37-2.35). Venlafaxine specifically showed ...

A new study published in the Journal of Psychopharmacology found that serotonergic antidepressants like SSRIs and SNRIs can decrease psilocybin’s effects, Psychedelic Spotlight reports. Serotonergic ...

Antidepressants: the most common prescription medication among cool people like artists, fictional type As, film protagonists and yourself. If you’ve been diagnosed with depression, your healthcare ...

Researchers analysed and then meta-analysed data from two register-based, nationwide cohort studies in Finland (1996-2017) and Sweden (2006-2023) and included 23,206 patients with schizophrenia (mean ...

Compared with no antidepressant use, there was a significantly reduced risk of non-exudative AMD and exudative AMD with use of SSRIs, SNRIs, or tricyclic antidepressants. Depression and AMD share ...

Major depressive disorder (MDD) is a severe form of depression characterized by a persistent low mood, hopelessness, ...

Among most ischemic (clot-caused) stroke survivors including those taking anticoagulant medications, use of antidepressants in the SSRI or SNRI class did not increase the risk of hemorrhagic (bleeds) ...

Antidepressant discontinuation actually conferred a slightly lower risk for psychiatric-related hospitalizations by 1.5 years postpartum. Discontinuing antidepressants like selective serotonin ...